Tagged with B

UAE The UAE’s rapid economic growth over the last half-century has been accompanied by a surge in lifestyle diseases such as diabetes and obesity. Both public and private organizations are now stepping up to tackle this health and economic burden with expanded access to cutting-edge treatments, a greater focus on education…

Artificial Intelligence IBM Watson Health’s Director for Global Life Sciences & Go-To Market Leader for Europe & Asia Pacific Christina Busmalis gives her insights into how AI and greater utilisation of real-world evidence is shaping the global biopharmaceutical industry, including the tangible results she has seen so far, and the lengthy path…

Hungary Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European market with more affordable biologic medicines and bolstering Hungary’s footprint in biologics R&D.   Biosimilars in Europe Over the past decade, over 80 biologic molecules have been launched worldwide. By 2020…

USA The AAM’s Chip Davis examines the roadblocks to greater adoption of biosimilar drugs in the USA, and why they need to be removed to potentially save billions of dollars and increase patient access to lifesaving medications.     In a nutshell: competition brings prices down across the board Biologic drugs…

UAE The mission of the Swiss Business Council (SBC) is to provide a forum for Swiss executives and those with Swiss business interested to identify, discuss and pursue common interests regarding their activities. Peter Harradine, president of SBC Dubai & Northern Emirates discusses FDI inflows into the UAE, the strategic significance…

Puerto Rico Iliette Frontera, VP Operations of Boston Scientific in Puerto Rico, shares the significance of the Dorado site within the group’s global supply chain, her four priorities to ensure sustainable growth, lessons learned from Hurricane Maria, and the importance of gender equality.   You have to be extremely agile and you…

Taiwan While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market, rising medical needs in Asia are helping foster more regionally-focused strategies.   According to data from the World Bank, healthcare spending in Asia is expected to grow at a CAGR of 9.2…

Switzerland Indian generics powerhouse Dr. Reddy’s has prioritized biosimilars as a key component of the global organization’s ongoing transition into a specialty pharma company.   As one of the first companies in the developing world to branch out into this segment – launching four biosimilar products between 2001 and 2011 –…

Switzerland Worldwide, severe side effects from classic medicine are becoming a health risk in themselves, often misdiagnosed as symptoms of other problems, resulting in further prescriptions, further side effects and unanticipated drug interactions; the so-called ‘prescription cascade’. Saad Harti, founder and CEO of botanical biopharma company Legacy Healthcare, describes this situation as “a…

Sweden The 2019 Nobel Prize in Physiology or Medicine was awarded to three scientists for their discovery of how cells sense and adapt to oxygen availability. Since the establishment of the Nobel Assembly in 1901 at the Karolinska Institute in Sweden, 219 researchers have been awarded the Nobel Prize in Physiology…

Sweden Richard Wikner, country manager of Lundbeck Sweden, explains the affiliate’s strategic significance to the research-based company and its role in raising awareness about mental illnesses in the region, in addition to the company’s mission of striving to help patients return to their normal lives following depression.   [Sweden] still remains…

China Kevin Pan, CEO of Asieris, shares the origins behind the company’s distinctive name and how it reflects their ambition to bridge scientific discoveries and innovative medicines; their focus on genitourinary (GU) tumours and related disease because of the significant and oft-overlooked medical needs there; and the importance of building and…